11:51 AM EST - BriaCell Therapeutics Corp : has formally engaged Dr. Steven J. O'Day as Principal Investigator for the Company's upcoming BriaVax™ vaccine clinical trial. Dr. O'Day is a highly specialized oncologist with a history of leading successful clinical trials, having been educated and trained at Johns Hopkins, Harvard, and Oxford. BriaCell Therapeutics Corp
shares V.BCT are trading unchanged at $0.18.
